Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Post by Pocketsundialon Jan 03, 2018 11:24am

126 Views

Post# 27270866

Some people just dont know value

Read the market and read the people. Ignore the negative and embrace the truths. If you can't think straight under pressure go invest in a GIC. From 1995 to present, Pokemon cards have outperformed gold by more than 3000% and trust me, there was a massive market downturn when you couldn't even pay people to take them. Value finds the surface every time.

Bullboard Posts

Day trading vs. swing trading strategies for small-cap stocks